{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:54:01Z","timestamp":1792713241796,"version":"4.5.0"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Complement not only plays a key role in host microbial defense but also modulates the adaptive immune response through modification of T- and B-cell reactivity. Moreover, a normally functioning complement system participates in hematopoiesis, reproduction, lipid metabolism, and tissue regeneration. Because of its powerful inflammatory potential, multiple regulatory proteins are needed to prevent potential tissue damage. In clinical practice, dysregulation and overactivation of the complement system are major causes of a variety of inflammatory and autoimmune diseases ranging from nephropathies, age-related macular degeneration (AMD), and systemic lupus erythematosus (SLE) to graft rejection, sepsis, and multi-organ failure. The clinical importance is reflected by the recent development of multiple drugs targeting complement with a broad spectrum of indications. The recognition of the role of complement in diverse diseases and the advent of complement therapeutics has increased the number of laboratories and suppliers entering the field. This has highlighted the need for reliable complement testing. The relatively rapid expansion in complement testing has presented challenges for a previously niche field. This is exemplified by the issue of cross-reactivity of complement-directed antibodies and by the challenges of the poor stability of many of the complement analytes. The complex nature of complement testing and increasing clinical demand has been met in the last decade by efforts to improve the standardization among laboratories. Initiated by the\n                    <jats:italic>IUIS\/ICS Committee for the Standardization and Quality Assessment in Complement Measurements<\/jats:italic>\n                    14 rounds of external quality assessment since 2010 resulted in improvements in the consistency of testing across participating institutions, while extending the global reach of the efforts to more than 200 laboratories in 30 countries. Worldwide trends of assay availability, usage, and analytical performance are summarized based on the past years\u2019 experiences. Progress in complement analysis has been facilitated by the quality assessment and standardization efforts that now allow complement testing to provide a comprehensive insight into deficiencies and the activation state of the system. This in turn enables clinicians to better define disease severity, evolution, and response to therapy.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.697313","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T02:13:37Z","timestamp":1628475217000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Expanding Horizons in Complement Analysis and Quality Control"],"prefix":"10.3389","volume":"12","author":[{"given":"Ashley","family":"Frazer-Abel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kirschfink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: A Key System for Immune Surveillance and Homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3858","article-title":"Novel Mechanisms and Functions of Complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molimm.2019.07.018","article-title":"The Hijackers Guide to Escaping Complement: Lessons Learned From Pathogens","volume":"114","author":"Ermert","year":"2019","journal-title":"Mol Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","article-title":"Intracellular Complement - the Complosome - in Immune Cell Regulation","volume":"89","author":"Arbore","year":"2017","journal-title":"Mol Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053245","article-title":"Complement and the Regulation of T Cell Responses","volume":"36","author":"West","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-2776(08)60379-X","article-title":"Acute Phase Proteins With Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein","volume":"34","author":"Pepys","year":"1983","journal-title":"Adv Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12952","article-title":"Production of Complement Components by Cells of the Immune System","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-012-2924-6","article-title":"Complement Genetics, Deficiencies, and Disease Associations","volume":"3","author":"Mayilyan","year":"2012","journal-title":"Protein Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I - Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01308","article-title":"Complement Nomenclature-Deconvoluted","volume":"10","author":"Bohlson","year":"2019","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718709115","article-title":"Structure of the C1r-C1s Interaction of the C1 Complex of Complement Activation","volume":"115","author":"Almitairi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A Journey Through the Lectin Pathway of Complement-MBL and Beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12473","article-title":"Old Dogs-New Tricks: Immunoregulatory Properties of C3 and C5 Cleavage Fragments","volume":"274","author":"Verschoor","year":"2016","journal-title":"Immunol Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1038\/s41467-018-07653-5","article-title":"CryoEM Reveals How the Complement Membrane Attack Complex Ruptures Lipid Bilayers","volume":"9","author":"Menny","year":"2018","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nri2620","article-title":"Complement Regulators and Inhibitory Proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101250","article-title":"Properdin: Emerging Roles of a Pattern-Recognition Molecule","volume":"28","author":"Kemper","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02097","article-title":"Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b","volume":"10","author":"van den Bos","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The Central Role of the Alternative Complement Pathway in Human Disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01936","article-title":"Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-Total Complement Deficiencies","volume":"10","author":"El Sissy","year":"2019","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious Diseases Associated With Complement Deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are Complement Deficiencies Really Rare? Overview on Prevalence, Clinical Importance and Modern Diagnostic Approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.molimm.2019.08.002","article-title":"Complement Deficiencies and Dysregulation: Pathophysiological Consequences, Modern Analysis, and Clinical Management","volume":"114","author":"Schroder-Braunstein","year":"2019","journal-title":"Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global Systematic Review of Primary Immunodeficiency Registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01491","article-title":"Primary Immunodeficiencies in Russia: Data From the National Registry","volume":"11","author":"Mukhina","year":"2020","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00754-1","article-title":"European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management","volume":"40","author":"Brodszki","year":"2020","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10875-015-0137-5","article-title":"Spectrum and Management of Complement Immunodeficiencies (Excluding Hereditary Angioedema) Across Europe","volume":"35","author":"Turley","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary Angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/all.13384","article-title":"The International WAO\/EAACI Guideline for the Management of Hereditary Angioedema-The 2017 Revision and Update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.03.008","article-title":"The Expanding Spectrum of Mutations in Hereditary Angioedema","volume":"9","author":"Veronez","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The Complement System in Systemic Lupus Erythematosus: An Update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101331","DOI":"10.1016\/j.smim.2019.101331","article-title":"Complement Dysregulation in Glomerulonephritis","volume":"45","author":"Kaartinen","year":"2019","journal-title":"Semin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of Complement Dysregulation-An Overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03796-9","article-title":"The Complement System in Age-Related Macular Degeneration","volume":"78","author":"Armento","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00341","article-title":"Which Pathways Trigger the Role of Complement in Ischaemia\/Reperfusion Injury","volume":"3","author":"Farrar","year":"2012","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001593","article-title":"Complement Is Alive and Well","volume":"44","author":"Ward","year":"2016","journal-title":"Crit Care Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02050","article-title":"Complement After Trauma: Suturing Innate and Adaptive Immunity","volume":"9","author":"Chakraborty","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-Mediated Events in Alzheimer\u2019s Disease: Mechanisms and Potential Therapeutic Targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8961-8","article-title":"The Complement System as a Biomarker of Disease Activity and Response to Treatment in Multiple Sclerosis","volume":"65","author":"Tatomir","year":"2017","journal-title":"Immunol Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-32-9636-7_20","article-title":"Guillain-Barre Syndrome","volume":"1190","author":"Kaida","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00830-z","article-title":"Broadly Effective Metabolic and Immune Recovery With C5 Inhibition in CHAPLE Disease","volume":"22","author":"Ozen","year":"2021","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003812","article-title":"How I Treat Paroxysmal Nocturnal Hemoglobinuria","volume":"137","author":"Brodsky","year":"2021","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05435.x","article-title":"Complement and Biocompatibility","author":"Mollnes","year":"1998","journal-title":"Vox Sang"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00071","article-title":"The Complement System in Dialysis: A Forgotten Story","volume":"9","author":"Poppelaars","year":"2018","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/1010-7940(93)90241-3","article-title":"Organ Dysfunction and Cardiopulmonary Bypass: The Role of Complement and Complement Regulatory Proteins","volume":"7","author":"Moat","year":"1993","journal-title":"Eur J Cardiothorac Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90962","article-title":"The Role of the Complement System in Cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00752","article-title":"Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention","volume":"10","author":"Fishelson","year":"2019","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000512494","article-title":"Complement-Related Proteins and Their Measurements: The Current Status of Clinical Investigation","author":"Ohtani","year":"2020","journal-title":"Nephron"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the Complement System in the Clinical Immunology Laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin Lab Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02539","article-title":"Current and Future Approaches for Monitoring Responses to Anti-Complement Therapeutics","volume":"10","author":"Mohebnasab","year":"2019","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.06.001","article-title":"Complement Analysis in the Era of Targeted Therapeutics","volume":"102","author":"Prohaszka","year":"2018","journal-title":"Mol Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080070084040","article-title":"Cellular and Humoral Anticorneal Immune Response in Corneal Transplantation","volume":"109","author":"Jager","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4657","article-title":"Complement, a Target for Therapy in Inflammatory and Degenerative Diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B56","volume-title":"Complement Factsbook","author":"Barnum","year":"2017"},{"key":"B57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A Review of Complement Activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-1016-9_1","article-title":"The Benefits of Complement Measurements for the Clinical Practice","volume":"2227","author":"Grunenwald","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00794","article-title":"Patterns of C1-Inhibitor\/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients","volume":"11","author":"Kajdacsi","year":"2020","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-62703-724-2_16","article-title":"C1 Inhibitor: Quantification and Purification","volume":"1100","author":"Varga","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B61","first-page":"133","article-title":"Complement and Complement Fixation","volume-title":"Experimental Immunochemistry","author":"Mayer","year":"1967"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.4.586","article-title":"Automated Homogeneous Liposome-Based Assay System for Total Complement Activity","volume":"41","author":"Yamamoto","year":"1995","journal-title":"Clin Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.05.003","article-title":"European Union Funded Project on the Development of a Whole Complement Deficiency Screening ELISA-A Story of Success and an Exceptional Manager: Mohamed R","volume":"68","author":"Wurzner","year":"2015","journal-title":"Daha Mol Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.6.1.137-139.1999","article-title":"Comparison of Three Different Methods for Measuring Classical Pathway Complement Activity","volume":"6","author":"Jaskowski","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12388","article-title":"A Novel Method for Direct Measurement of Complement Convertases Activity in Human Serum","volume":"178","author":"Blom","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e05899","DOI":"10.1016\/j.heliyon.2021.e05899","article-title":"CH50 as a Putative Biomarker of Eculizumab Treatment in Neuromyelitis Optica Spectrum Disorder","volume":"7","author":"Namatame","year":"2021","journal-title":"Heliyon"},{"key":"B67","doi-asserted-by":"publisher","first-page":"112944","DOI":"10.1016\/j.jim.2020.112944","article-title":"Monitoring Ravulizumab Effect on Complement Assays","volume":"490","author":"Willrich","year":"2021","journal-title":"J Immunol Methods"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12890","article-title":"Monitoring of Complement Activation Biomarkers and Eculizumab in Complement-Mediated Renal Disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa139.SO054","article-title":"Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults","volume":"6","author":"Barbour","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1279","DOI":"10.1002\/cti2.1279","article-title":"Autoantibodies Against Complement Component C1q in Systemic Lupus Erythematosus","volume":"10","author":"Trendelenburg","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H Autoantibodies in Membranoproliferative Glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.05.009","article-title":"Autoantibodies Against Complement Components and Functional Consequences","volume":"56","author":"Dragon-Durey","year":"2013","journal-title":"Mol Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imbio.2013.06.004","article-title":"Standardisation of the Factor H Autoantibody Assay","volume":"219","author":"Watson","year":"2014","journal-title":"Immunobiology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585108","article-title":"Soluble Membrane Attack Complex: Biochemistry and Immunobiology","volume":"11","author":"Barnum","year":"2020","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/2.5.413","article-title":"Incorporation of SP-40,40 Into the Soluble Membrane Attack Complex (SMAC, SC5b-9) of Complement","volume":"2","author":"Choi","year":"1990","journal-title":"Int Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.569291","article-title":"Validation of Early Increase in Complement Activation Marker Sc5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation","volume":"7","author":"Mezo","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-020-01407-z","article-title":"Soluble Terminal Complement Activation Fragment Sc5b-9: A New Serum Biomarker for Traumatic Brain Injury","author":"Parry","year":"2020","journal-title":"Eur J Trauma Emerg Surg"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab Reduces Complement Activation, Inflammation, Endothelial Damage, Thrombosis, and Renal Injury Markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004218","article-title":"Complement Blockade for TA-TMA: Lessons Learned From a Large Pediatric Cohort Treated With Eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of Complement Activation in aHUS and How to Monitor Eculizumab Therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01820214","article-title":"Defining the Complement Biomarker Profile of C3 Glomerulopathy","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01691","article-title":"Functional Characterization of Alternative and Classical Pathway C3\/C5 Convertase Activity and Inhibition Using Purified Models","volume":"9","author":"Zwarthoff","year":"2018","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1002\/cti2.1225","article-title":"Quantitative Multiplex Profiling of the Complement System to Diagnose Complement-Mediated Diseases","volume":"9","author":"Willems","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00455","article-title":"Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies","volume":"11","author":"Dezfouli","year":"2020","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"030701","DOI":"10.11613\/BM.2019.030701","article-title":"Preanalytical Classical and Alternative Complement Pathway Activity Loss","volume":"29","author":"Vercauteren","year":"2019","journal-title":"Biochem Med (Zagreb)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B88","article-title":"Effect of Time, Temperature and Anticoagulants on In Vitro Complement Activation: Consequences for Collection and Preservation of Samples to be Examined for Complement Activation","volume":"73","author":"Mollnes","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.04.002","article-title":"Diagnostics Reform and Harmonization of Clinical Laboratory Testing","volume":"21","author":"Schreier","year":"2019","journal-title":"J Mol Diagn"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2016.06.008","article-title":"Complement Analysis 2016: Clinical Indications, Laboratory Diagnostics and Quality Control","volume":"221","author":"Prohaszka","year":"2016","journal-title":"Immunobiology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molimm.2013.11.021","article-title":"An ELISA Assay With Two Monoclonal Antibodies Allows the Estimation of Free Factor H and Identifies Patients With Acquired Deficiency of This Complement Regulator","volume":"58","author":"Nozal","year":"2014","journal-title":"Mol Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00886","article-title":"Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations","volume":"10","author":"Corvillo","year":"2019","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(82)90386-6","article-title":"A New Screening Test for C3 Nephritis Factor Based on a Stable Cell Bound Convertase on Sheep Erythrocytes","volume":"51","author":"Rother","year":"1982","journal-title":"J Immunol Methods"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8949-2_15","article-title":"Anti-Factor H Autoantibodies Assay by ELISA","volume":"1901","author":"Senant","year":"2019","journal-title":"Methods Mol Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.697313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T02:13:44Z","timestamp":1628475224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.697313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2021.697313"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.697313","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"article-number":"697313"}}